Skip to main content

Table 2 Immunohistochemistry results of IDO and PD-L1

From: Role of IDO expression in patients with locally advanced rectal cancer treated with preoperative chemoradiotherapy

Staining intensity

n (%)

Distribution

n (%)

Total score

n (%)

< IDO expression>

0, no staining

52 (58%)

0, 0%

52 (58%)

0

52 (58%)

1+, weak staining

2 (2%)

1+, 1–9%

8 (9%)

1

0

2+, moderate staining

15 (17%)

2+, 10–50%

21 (23%)

2

0

3+, string staining

21 (23%)

3+, 51–80%

8 (9%)

3

8 (9%)

 

4+, 81–100%

1 (1%)

4

3 (33%)

   

5

25 (28%)

   

6

1 (1%)

   

7

1 (1%)

< PD-L1 expression>

0, no staining

18 (20%)

0, 0–5%

18 (20%)

0

18 (20%)

1+, weak staining

23 (26%)

1+, 6–25%

16 (18%)

1

0

2+, moderate staining

38 (42%)

2+, 26–50%

38 (42%)

2

6 (7%)

3+, string staining

11 (12%)

3+, 51–75%

11 (12%)

3

20 (22%)

 

4+, 76–100%

7 (8%)

4

25 (28%)

   

5

14 (16%)

   

6

5 (5%)

   

7

2 (2%)